Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.45 - $0.86 $1,561 - $2,983
-3,469 Reduced 46.09%
4,057 $2,000
Q2 2022

Aug 15, 2022

BUY
$0.47 - $0.87 $453 - $839
965 Added 14.71%
7,526 $4,000
Q1 2022

May 13, 2022

BUY
$0.75 - $1.77 $3,410 - $8,048
4,547 Added 225.77%
6,561 $5,000
Q4 2021

Feb 14, 2022

BUY
$1.56 - $2.93 $3,141 - $5,901
2,014 New
2,014 $3,000
Q2 2021

Aug 16, 2021

SELL
$4.17 - $5.74 $415,553 - $572,008
-99,653 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$4.9 - $7.12 $172,308 - $250,374
35,165 Added 54.53%
99,653 $609,000
Q2 2020

Aug 13, 2020

BUY
$6.43 - $9.86 $2,314 - $3,549
360 Added 0.56%
64,488 $468,000
Q1 2020

May 13, 2020

BUY
$6.36 - $10.05 $171,529 - $271,048
26,970 Added 72.58%
64,128 $446,000
Q4 2019

Feb 14, 2020

BUY
$8.49 - $12.81 $96,336 - $145,355
11,347 Added 43.96%
37,158 $328,000
Q3 2019

Nov 14, 2019

BUY
$5.58 - $14.47 $133,657 - $346,599
23,953 Added 1289.18%
25,811 $289,000
Q2 2019

Aug 14, 2019

BUY
$5.22 - $9.08 $2,824 - $4,912
541 Added 41.08%
1,858 $11,000
Q1 2019

May 10, 2019

SELL
$5.35 - $9.82 $12,417 - $22,792
-2,321 Reduced 63.8%
1,317 $10,000
Q4 2018

Feb 13, 2019

BUY
$3.43 - $6.19 $8,424 - $15,202
2,456 Added 207.78%
3,638 $18,000
Q3 2018

Nov 13, 2018

BUY
$4.75 - $14.5 $5,614 - $17,139
1,182 New
1,182 $6,000
Q2 2018

Aug 10, 2018

SELL
$13.3 - $17.45 $755,014 - $990,601
-56,768 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$14.7 - $24.95 $756,594 - $1.28 Million
-51,469 Reduced 47.55%
56,768 $911,000
Q4 2017

Feb 14, 2018

BUY
$19.9 - $29.25 $270,620 - $397,770
13,599 Added 14.37%
108,237 $0
Q3 2017

Nov 13, 2017

BUY
$15.1 - $19.25 $1.43 Million - $1.82 Million
94,638
94,638 $1.75 Million

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.